Q BioMed Closes Licensing Option Deal for FDA Approved Drug – Revenue Expected in 12 Months Biotech Investing
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy Life Science Investing
PetLife Pharmaceuticals Announces pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™ has Begun Life Science Investing
Aequus Pharmaceuticals Inc. Announces $2.0 to $4.0 Million Best Efforts Financing Life Science Investing
Mount Tam Biotechnologies, Inc., Announces Dr. Bryan F. Cox to join our Scientific Advisory Board Life Science Investing
Aquinox Pharmaceuticals Initiates Patient Dosing in LEADERSHIP 301 Phase 3 Clinical Trial of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome Life Science Investing
Tiotropium Respimat® improved lung function in children with asthma aged 6-17 and is well-tolerated compared to placebo in children aged 1-171-5 Life Science Investing
